Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer

Clinical efficacy and safety analysis of aumolertinib in real-world treatment of EGFR-mutated advanced non-small-cell lung cancer

Background: This study aims to determine the efficacy and safety profile of aumolertinib in the real-word treatment setting for advanced non-small-cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations.Methods: We retrospectively analyzed the clinical data of 1...

Full description

Bibliographic Details
Main Authors: Xiaojuan Zhang, Mina Zhang, Xinyang Du, Guowei Zhang, Yuanyuan Niu, Chunhua Wei, Lanwei Guo, Chao Shi, Hangfan Liu, Huijuan Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Pharmacology
Subjects:
non-small-cell lung cancer
EGFR
aumolertinib
elevated creatine kinase
T790M
brain metastasis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1331138/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1331138/full

Similar Items